Evidence map›Paper›PMID 31739453›Full record

ArticleMarine drugs2019

A Microbiological, Toxicological, and Biochemical Study of the Effects of Fucoxanthin, a Marine Carotenoid, on

Miroslava Šudomová, Mohammad Ali Shariati, Javier Echeverría, Ioana Berindan-Neagoe, Seyed Mohammad Nabavi, Sherif T S Hassan

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 4 countries.

Miroslava ŠudomováMuseum of Literature in Moravia, Klášter 1, 664 61 Rajhrad, Czech Republic.
Mohammad Ali ShariatiKazakh Research Institute of Processing and Food Industry (Semey Branch), Semey 071410, Kazakhstan.
Javier EcheverríaDepartamento de Ciencias del Ambiente, Facultad de Química y Biología, Universidad de Santiago de Chile, Casilla 40, Correo 33, Santiago 9170022, Chile.ORCID 0000-0002-1688-968X
Ioana Berindan-NeagoeResearch Center for Functional Genomics, Biomedicine and Translational Medicine, University of Medicine and Pharmacy "Iuliu-Hatieganu", 400337 Cluj-Napoca, Romania.ORCID 0000-0003-3856-3784
Seyed Mohammad NabaviApplied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran 14359-16471, Iran.
Sherif T S HassanDepartment of Natural Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackého tř. 1946/1, 612 42 Brno, Czech Republic.ORCID 0000-0003-3922-2738
Baqiyatallah University of Medical Sciences · IRIuliu Hațieganu University of Medicine and Pharmacy · ROUniversidad de Santiago de Chile · CLUniversity of Veterinary Sciences Brno · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study explored the antitubercular properties of fucoxanthin, a marine carotenoid, against clinical isolates of

Indexed as

Antitubercular AgentsArylamine N-AcetyltransferaseAutoimmune DiseasesCarotenoidsCell LineCell WallHumansIntramolecular TransferasesIsoenzymesMicrobial Sensitivity TestsMolecular Docking SimulationMycobacterium tuberculosisTuberculosisXanthophyllsAntitubercular AgentsArylamine N-AcetyltransferaseCarotenoidsfucoxanthinIntramolecular TransferasesIsoenzymesN-acetyltransferase 1UDP-galactopyranose mutaseXanthophyllsarylamine-N-acetyltransferaseautoimmunityfucoxanthinmarine carotenoidMycobacterium tuberculosispathogenesisUDP-galactopyranose mutase

Identifiers

PMID31739453
PMCPMC6891772
OpenAlexW2988944004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.